Clostridium difficile Infection: A Comprehensive Review

References

• Aas J, Gessert CE, Bakken JS. (2003). Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis, 36, 580–5.
   PubMed Web of Science ®Google Scholar
• Aldeen WE, Bingham M, Aiderzada A, Kucera J, Jense S, Carroll KC. (2000). Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. Diagn Microbiol Infect Dis, 36, 211–3.
   PubMedGoogle Scholar
• Ananthakrishnan AN. (2011). Clostridium difficile infection: epidemiology, risk factors, and management. Nat Rev Gastroenterol Hepatol, 8, 17–26.
   PubMed Web of Science ®Google Scholar
• Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE, Weese JS. (2005). PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol, 54, 163–6.
   PubMed Web of Science ®Google Scholar
• Ash L, Baker ME, O’Malley CM, Jr., Gordon SM, Delaney CP, Obuchowski NA. (2006). Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. AJR Am J Roentgenol, 186, 1393–400.
   PubMed Web of Science ®Google Scholar
• Aslam S, Hamill RJ, Musher DM. (2005). Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis, 5, 549–57.
   PubMed Web of Science ®Google Scholar
• Barbut F, Decre D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC. (2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol, 54, 181–5.
   PubMed Web of Science ®Google Scholar
• Barbut F, Delmee M, Brazier JS, Petit JC, Poxton IR, Rupnik M, Lalande V, Schneider C, Mastrantonio P, Alonso R, Kuipjer E, Tvede M. (2003). A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect, 9, 989–96.
   PubMed Web of Science ®Google Scholar
• Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I. (2007). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect, 13, 1048–57.
   PubMed Web of Science ®Google Scholar
• Bartlett JG. (1981). Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J, 149, 6–9.
   PubMedGoogle Scholar
• Bartlett JG. (1994). Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis, 18 Suppl 4, S265–72.
   PubMed Web of Science ®Google Scholar
• Bartlett JG. (2002). Clinical practice. Antibiotic-associated diarrhea. N Engl J Med, 346, 334–9.
   PubMed Web of Science ®Google Scholar
• Bartlett JG. (2006). Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med, 145, 758–64.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Perl TM. (2005). The new Clostridium difficile—what does it mean? N Engl J Med, 353, 2503–5.
   PubMed Web of Science ®Google Scholar
• Bauer MP, Notermans DW, Van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, Van Dissel JT, Kuijper EJ. (2011). Clostridium difficile infection in Europe: a hospital-based survey. Lancet, 377, 63–73.
   PubMed Web of Science ®Google Scholar
• Bauwens JE, Mcfarland LV, Melcher SA. (1997). Recurrent Clostridium difficile disease following ciprofloxacin use. Ann Pharmacother, 31, 1090.
   PubMed Web of Science ®Google Scholar
• Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. (1999). Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett, 175, 261–6.
   PubMed Web of Science ®Google Scholar
• Boyce JM, Ligi C, Kohan C, Dumigan D, Havill NL. (2006). Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol, 27, 479–83.
   PubMed Web of Science ®Google Scholar
• Burns K, Morris-Downes M, Fawley WN, Smyth E, Wilcox MH, Fitzpatrick F. (2010). Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland. J Hosp Infect, 75, 287–91.
   PubMedGoogle Scholar
• Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. (2008). Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg, 143, 150–4; discussion 155.
   PubMed Web of Science ®Google Scholar
• Carter GP, Lyras D, Allen DL, Mackin KE, Howarth PM, O’Connor JR, Rood JI. (2007). Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol, 189, 7290–301.
   PubMed Web of Science ®Google Scholar
• Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, Mcdonald LC, Pepin J, Wilcox MH. (2010). Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol, 31, 431–55.
   PubMed Web of Science ®Google Scholar
• Crobach MJT, Dekkers OM, Wilcox MH, Kuijper EJ. (2009). European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect, 15, 1053–66.
   PubMed Web of Science ®Google Scholar
• Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL. (2002). Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg, 235, 363–72.
   PubMed Web of Science ®Google Scholar
• Delmee M. (2001). Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect, 7, 411–6.
   PubMed Web of Science ®Google Scholar
• Delmee M, Verellen G, Avesani V, Francois G. (1988). Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr, 147, 36–40.
   PubMed Web of Science ®Google Scholar
• Dial S, Delaney JA, Barkun AN, Suissa S. (2005). Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA, 294, 2989–95.
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, Burstin H, Calfee DP, Coffin SE, Fraser V, Griffin FA, Gross P, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS. (2008). Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol, 29 Suppl 1, S81–92
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Reske KA, Noble-Wang J, Thompson A, Killgore G, Mayfield J, Camins B, Woeltje K, McDonald JR, McDonald LC, Fraser VJ. (2007). Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control, 35, 315–8.
   PubMed Web of Science ®Google Scholar
• Dupuy B, Govind R, Antunes A, Matamouros S. (2008). Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol, 57, 685–9.
   PubMedGoogle Scholar
• Falsen E, Kaijser B, Nehls L, Nygren B, Svedhem A. (1980). Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol, 12, 297–300.
   PubMed Web of Science ®Google Scholar
• Farrell RJ, LaMont JT. (2000). Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol, 250, 109–25.
   PubMedGoogle Scholar
• Fekety R. (1997). Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 92, 739–50.
   PubMed Web of Science ®Google Scholar
• Fekety R, Shah AB. (1993). Diagnosis and treatment of Clostridium difficile colitis. JAMA, 269, 71–5.
   PubMed Web of Science ®Google Scholar
• Freiler JF, Durning SJ, Ender PT. (2001). Clostridium difficile small bowel enteritis occurring after total colectomy. Clin Infect Dis, 33, 1429–31; discussion 32.
   PubMed Web of Science ®Google Scholar
• Frenz MB, McIntyre AS. (2003). Reducing delays in the diagnosis and treatment of Clostridium difficile diarrhoea. QJM, 96, 579–82.
   PubMed Web of Science ®Google Scholar
• Gebhard RL, Gerding DN, Olson MM, Peterson LR, Mcclain CJ, Ansel HJ, Shaw MJ, Schwartz ML. (1985). Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis. Am J Med, 78, 45–8.
   PubMedGoogle Scholar
• George WL, Sutter VL, Citron D, Finegold SM. (1979). Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol, 9, 214–9.
   PubMed Web of Science ®Google Scholar
• Gerding DN, Muto CA, Owens RC Jr. (2008a). Measures to control and prevent Clostridium difficile infection. Clin Infect Dis, 46 Suppl 1, S43–9.
   PubMed Web of Science ®Google Scholar
• Gerding DN, Muto CA, Owens RC Jr. (2008b). Treatment of Clostridium difficile infection. Clin Infect Dis, 46 Suppl 1, S32–42
   PubMedGoogle Scholar
• Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. (2008). Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis, 47, 1162–70.
   PubMed Web of Science ®Google Scholar
• Goorhuis A, Van Der Kooi T, Vaessen N, Dekker FW, Van Den Berg R, Harmanus C, Van Den Hof S, Notermans DW, Kuijper EJ. (2007). Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis, 45, 695–703.
   PubMed Web of Science ®Google Scholar
• Gould LH, Limbago B. (2010). Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis, 51, 577–82.
   PubMed Web of Science ®Google Scholar
• Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, Kirton R, Peto TE, Rees G, Stoesser N, Vaughan A, Walker AS, Young BC, Wilcox M, Dingle KE. (2010). Multilocus sequence typing of Clostridium difficile. J Clin Microbiol, 48, 770–8.
   PubMed Web of Science ®Google Scholar
• Halsey J. (2008). Current and future treatment modalities for Clostridium difficile-associated disease. Am J Health Syst Pharm, 65, 705–15.
   PubMed Web of Science ®Google Scholar
• Janezic S, Rupnik M. (2010). Molecular typing methods for Clostridium difficile: pulsed-field gel electrophoresis and PCR ribotyping. Methods Mol Biol, 646, 55–65.
   PubMedGoogle Scholar
• Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, Mcdonald LC, Limbago BM. (2008). Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis, 14, 1039–45.
   PubMed Web of Science ®Google Scholar
• Johal SS, Hammond J, Solomon K, James PD, Mahida YR. (2004). Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut, 53, 673–7.
   PubMed Web of Science ®Google Scholar
• Kato H, Kato N, Watanabe K, Ueno K, Ushijima H, Hashira S, Abe T. (1994). Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J Clin Microbiol, 32, 2067–70.
   PubMed Web of Science ®Google Scholar
• Keven K, Basu A, Re L, Tan H, Marcos A, Fung JJ, Starzl TE, Simmons RL, Shapiro R. (2004). Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis, 6, 10–4.
   PubMedGoogle Scholar
• Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, Frost EH, Savelkoul P, Nicholson B, Van Den Berg RJ, Kato H, Sambol SP, Zukowski W, Woods C, Limbago B, Gerding DN, Mcdonald LC. (2008). Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol, 46, 431–7.
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Richards CL, Jr., Horan TC, Gaynes RP, Pollock DA, Cardo DM. (2007). Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep, 122, 160–6.
   PubMed Web of Science ®Google Scholar
• Koo HL, Garey KW, Dupont HL. (2010). Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs, 19, 825–36.
   PubMed Web of Science ®Google Scholar
• Kuijper EJ, Coignard B, Tull P. (2006). Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect, 12 Suppl 6, 2–18.
   Google Scholar
• Kyne L, Warny M, Qamar A, Kelly CP. (2001). Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet, 357, 189–93.
   PubMed Web of Science ®Google Scholar
• Lamontagne F, Labbe AC, Haeck O, Lesur O, Lalancette M, Patino C, Leblanc M, Laverdiere M, Pepin J. (2007). Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg, 245, 267–72.
   PubMed Web of Science ®Google Scholar
• Lawley TD, Clare S, Deakin LJ, Goulding D, Yen JL, Raisen C, Brandt C, Lovell J, Cooke F, Clark TG, Dougan G. (2010). Purified Clostridium difficile spores facilitate the evaluation of healthcare disinfection regimens. Appl Environ Microbiol.
   PubMedGoogle Scholar
• Levett PN. (1985). Effect of antibiotic concentration in a selective medium on the isolation of Clostridium-Difficile from fecal specimens. J Clin Pathol, 38, 233–34.
   PubMed Web of Science ®Google Scholar
• Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. (2005). A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med, 353, 2442–9.
   PubMed Web of Science ®Google Scholar
• Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI. (2009). Toxin B is essential for virulence of Clostridium difficile. Nature, 458, 1176–9.
   PubMed Web of Science ®Google Scholar
• MacCannell DR, Louie TJ, Gregson DB, Laverdiere M, Labbe AC, Laing F, Henwick S. (2006). Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol, 44, 2147–52.
   PubMed Web of Science ®Google Scholar
• Mani N, Dupuy B. (2001). Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A, 98, 5844–9.
   PubMed Web of Science ®Google Scholar
• Marsh JW, O’Leary MM, Shutt KA, Pasculle AW, Johnson S, Gerding DN, Muto CA, Harrison LH. (2006). Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol, 44, 2558–66.
   PubMed Web of Science ®Google Scholar
• Marsh JW, O’Leary MM, Shutt KA, Sambol SP, Johnson S, Gerding DN, Harrison LH. (2010). Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J Clin Microbiol, 48, 412–8.
   PubMed Web of Science ®Google Scholar
• Matamouros S, England P, Dupuy B. (2007). Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol, 64, 1274–88.
   PubMed Web of Science ®Google Scholar
• McDonald LC, Killgore GE, Thompson A, Owens RC, Jr., Kazakova SV, Sambol SP, Johnson S, Gerding DN. (2005). An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med, 353, 2433–41.
   PubMed Web of Science ®Google Scholar
• McFarland LV, Bauwens JE, Melcher SA, Surawicz CM, Greenberg RN, Elmer GW. (1995). Ciprofloxacin-associated Clostridium difficile disease. Lancet, 346, 977–8.
   PubMed Web of Science ®Google Scholar
• McFarland LV, Surawicz CM, Stamm WE. (1990). Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis, 162, 678–84.
   PubMed Web of Science ®Google Scholar
• McNulty C, Logan M, Donald IP, Ennis D, Taylor D, Baldwin RN, Bannerjee M, Cartwright KA. (1997). Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother, 40, 707–11.
   PubMed Web of Science ®Google Scholar
• Miller M. (2010). Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection. Expert Opin Pharmacother, 11, 1569–78.
   PubMed Web of Science ®Google Scholar
• Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. (2002). Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg, 137, 1096–100.
   PubMedGoogle Scholar
• Noren T. (2010). Clostridium difficile and the disease it causes. Methods Mol Biol, 646, 9–35.
   PubMedGoogle Scholar
• Owens RC, Jr., Donskey CJ, Gaynes RP, Loo VG, Muto CA. (2008). Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis, 46 Suppl 1, S19–31
   Google Scholar
• Pepin J, Routhier S, Gagnon S, Brazeau I. (2006). Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis, 42, 758–64.
   PubMed Web of Science ®Google Scholar
• Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pepin K, Chouinard D. (2004). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ, 171, 466–72.
   Google Scholar
• Pepin J, Valiquette L, Cossette B. (2005). Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ, 173, 1037–42.
   PubMed Web of Science ®Google Scholar
• Perry JD, Asir K, Halimi D, Orenga S, Dale J, Payne M, Carlton R, Evans J, Gould FK. (2010). Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours. J Clin Microbiol, 48, 3852–58.
   PubMed Web of Science ®Google Scholar
• Persson S, Torpdahl M, Olsen KE. (2008). New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect, 14, 1057–64.
   PubMed Web of Science ®Google Scholar
• Peterson LR, Kelly PJ, Nordbrock HA. (1996). Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis, 15, 330–6.
   PubMed Web of Science ®Google Scholar
• Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, Thomson RB, Jr., Kaul KL. (2007). Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis, 45, 1152–60.
   PubMed Web of Science ®Google Scholar
• Pillai A, Nelson R. (2008). Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev, 1, CD004611.
   Google Scholar
• Popoff MR, Rubin EJ, Gill DM, Boquet P. (1988). Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun, 56, 2299–306.
   PubMed Web of Science ®Google Scholar
• Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. (2007). Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis, 45, 992–8.
   PubMed Web of Science ®Google Scholar
• Rodemann JF, Dubberke ER, Reske KA, Seo Da H, Stone CD. (2007). Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol, 5, 339–44.
   PubMed Web of Science ®Google Scholar
• Rubin MS, Bodenstein LE, Kent KC. (1995). Severe Clostridium difficile colitis. Dis Colon Rectum, 38, 350–4.
   PubMed Web of Science ®Google Scholar
• Rupnik M. (2008). Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev, 32, 541–55.
   PubMed Web of Science ®Google Scholar
• Rupnik M, Wilcox MH, Gerding DN. (2009). Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol, 7, 526–36.
   PubMed Web of Science ®Google Scholar
• Shanholtzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN, Peterson LR. (1992). Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol, 30, 1837–40.
   PubMed Web of Science ®Google Scholar
• Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. (1998). Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet, 351, 633–6.
   PubMed Web of Science ®Google Scholar
• Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE. (2008). Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol, 46, 1996–2001.
   PubMed Web of Science ®Google Scholar
• Smith A. (2005). Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill, 10, E050630 2.
   Google Scholar
• Stubbs SL, Brazier JS, O’Neill GL, Duerden BI. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol, 37, 461–3.
   PubMed Web of Science ®Google Scholar
• Sun X, He X, Tzipori S, Gerhard R, Feng H. (2009). Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages. Microb Pathog, 46, 298–305.
   Google Scholar
• Sunenshine RH, McDonald LC. (2006). Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med, 73, 187–97.
   PubMed Web of Science ®Google Scholar
• Tan KS, Wee BY, Song KP. (2001). Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol, 50, 613–9.
   PubMed Web of Science ®Google Scholar
• Turgeon DK, Novicki TJ, Quick J, Carlson L, Miller P, Ulness B, Cent A, Ashley R, Larson A, Coyle M, Limaye AP, Cookson BT, Fritsche TR. (2003). Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol, 41, 667–70.
   PubMed Web of Science ®Google Scholar
• Venuto C, Butler M, Ashley ED, Brown J. (2010). Alternative therapies for Clostridium difficile infections. Pharmacotherapy, 30, 1266–78.
   PubMed Web of Science ®Google Scholar
• Voth DE, Ballard JD. (2005). Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev, 18, 247–63.
   PubMed Web of Science ®Google Scholar
• Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. (2005). Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet, 366, 1079–84.
   PubMed Web of Science ®Google Scholar